Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04272216 · ClinicalTrials.gov registry record
An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres
A clinical trial of Benign Prostatic Hyperplasia and Uterine Fibroid, sponsored by Terumo Medical Corporation.
- Completed
- Registry status
- 99
- Enrollment target
- 6
- Study locations
NCT04272216 is a study of Benign Prostatic Hyperplasia and Uterine Fibroid that has completed, run by Terumo Medical Corporation. The registered enrollment target is 99 participants, below the 549-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (82% lower). The trial reports 6 study locations across 6 states.
The verdict
NCT04272216, a study of Benign Prostatic Hyperplasia and Uterine Fibroid, has completed, sponsored by Terumo Medical Corporation.
- COMPLETED
- Registry status
- 99 participants
- Enrollment target
- 6
- Study locations
Study Summary
This registry study is designed to collect data on the procedural success and complication rates in real-world patients undergoing HydroPearl embolization procedures via radial access.
Conditions Studied
Interventions
- DEVICE Treatment with HydroPearl via radial access
Study Locations (6)
California
- University of California - Los Angeles - Los Angeles
Illinois
- Rush University Medical Center - Chicago
Missouri
- SLU Department of Radiology - St Louis
New York
- Mount Sinai - New York
North Carolina
- UNC - Chapel Hill
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2020-02-06 |
| Est. Completion | 2023-03-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04272216
The ClinicalTrials.gov registry entry for NCT04272216 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 549-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (82% lower). The listed sponsor is Terumo Medical Corporation, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Benign Prostatic Hyperplasia appearing as the primary indexed condition, and to 1 intervention - of which Treatment with HydroPearl via radial access is the first listed.
NCT04272216 reports 6 study locations spanning 6 distinct geographic areas - top geographies include California, Illinois, Missouri.
Frequently Asked Questions
What is clinical trial NCT04272216 about?
NCT04272216 is a clinical study titled "An Observational Study of Radial Access Embolization Procedures Using HydroPearl Microspheres". This registry study is designed to collect data on the procedural success and complication rates in real-world patients undergoing HydroPearl embolization procedures via radial access.
What is the current status of trial NCT04272216?
This trial is currently completed. The enrollment target is 99 participants. The study started on 2020-02-06. Estimated completion is 2023-03-11.
What conditions does trial NCT04272216 study?
This clinical trial studies the following conditions: Benign Prostatic Hyperplasia, Uterine Fibroid, Arteriovenous Malformations, Hypervascular Tumors.
What interventions are being tested in trial NCT04272216?
The interventions under investigation include: Treatment with HydroPearl via radial access (DEVICE).
Who is sponsoring clinical trial NCT04272216?
This trial is sponsored by Terumo Medical Corporation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04272216 being conducted?
This trial has 6 study locations across California, Illinois, Missouri, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Benign Prostatic Hyperplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Customized TULSA-PRO Ablation Registry
RECRUITING
-
OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH
RECRUITING
-
Ambulatory Long Length URodynamics Evaluation
RECRUITING · NA
-
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
RECRUITING · NA
-
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
RECRUITING · NA
-
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.